These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2571488)

  • 1. In vitro formation of an inhibitory complex between an isosafrole metabolite and rat hepatic cytochrome P-450 PB-B.
    Murray M; Reidy GF
    Drug Metab Dispos; 1989; 17(4):449-54. PubMed ID: 2571488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.
    Reidy GF; Mehta I; Murray M
    Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective reactivation of steroid hydroxylases following dissociation of the isosafrole metabolite complex with rat hepatic cytochrome P-450.
    Murray M; Zaluzny L; Farrell GC
    Arch Biochem Biophys; 1986 Dec; 251(2):471-8. PubMed ID: 3800378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.
    Ng SF; Waxman DJ
    Cancer Res; 1990 Feb; 50(3):464-71. PubMed ID: 2105156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered regulation of cytochrome P-450 enzymes in choline-deficient cirrhotic male rat liver: impaired regulation and activity of the male-specific androst-4-ene-3,17-dione 16 alpha-hydroxylase, cytochrome P-450UT-A, in hepatic cirrhosis.
    Murray M; Zaluzny L; Dannan GA; Guengerich FP; Farrell GC
    Mol Pharmacol; 1987 Jan; 31(1):117-21. PubMed ID: 3543647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based inactivation of the major beta-naphthoflavone-inducible isozyme of rat liver cytochrome P-450 by the chloramphenicol analog N-(2-p-nitrophenethyl)dichloroacetamide.
    Miller NE; Halpert JR
    Drug Metab Dispos; 1987; 15(6):846-51. PubMed ID: 2893712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cytochrome P-450c-mediated benzo[a]pyrene hydroxylase and ethoxyresorufin O-deethylase by dihydrosafrole.
    Kao LR; Wilkinson CF
    Xenobiotica; 1987 Jul; 17(7):793-805. PubMed ID: 3660849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibitory interactions of alkoxymethylenedioxybenzenes towards mono-oxygenase activity in rat-hepatic microsomes.
    Murray M; Hetnarski K; Wilkinson CF
    Xenobiotica; 1985 May; 15(5):369-79. PubMed ID: 4036165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
    Jeffery EH; Mannering GJ
    Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexation of cytochrome P-450 isozymes in hepatic microsomes from SKF 525-A-induced rats.
    Murray M
    Arch Biochem Biophys; 1988 May; 262(2):381-8. PubMed ID: 3364973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P-450 isoenzyme content and monooxygenase activities in rat liver: effect of ontogenesis and pretreatment by phenobarbital and 3-methylcholanthrene.
    Cresteil T; Beaune P; Celier C; Leroux JP; Guengerich FP
    J Pharmacol Exp Ther; 1986 Jan; 236(1):269-76. PubMed ID: 3941398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety.
    Labbe G; Descatoire V; Beaune P; Letteron P; Larrey D; Pessayre D
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1034-42. PubMed ID: 2506333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers.
    Bast A; Savenije-Chapel EM; Kroes BH
    Xenobiotica; 1984 May; 14(5):399-408. PubMed ID: 6089451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic-intermediate complex formation reveals major changes in rat hepatic cytochrome P-450 subpopulations in addition to those forms previously purified after phenobarbital, beta-naphthoflavone, and isosafrole induction.
    Bornheim LM; Franklin MR
    Mol Pharmacol; 1982 Mar; 21(2):527-32. PubMed ID: 7099151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of rat hepatic microsomal cytochrome P-450. I. Effect of the in vivo administration of cimetidine.
    Chang T; Levine M; Bandiera SM; Bellward GD
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1441-9. PubMed ID: 1545403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine.
    Prough RA; Brown MI; Dannan GA; Guengerich FP
    Cancer Res; 1984 Feb; 44(2):543-8. PubMed ID: 6692359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isozyme selectivity of the inhibition of rat liver cytochromes P-450 by chloramphenicol in vivo.
    Halpert J; Balfour C; Miller NE; Morgan ET; Dunbar D; Kaminsky LS
    Mol Pharmacol; 1985 Sep; 28(3):290-6. PubMed ID: 4033629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inactivation of four rat liver microsomal androstenedione hydroxylases by chloramphenicol analogs.
    Stevens JC; Halpert J
    Mol Pharmacol; 1988 Jan; 33(1):103-10. PubMed ID: 3336347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a reversible component in the in vitro inhibition of rat hepatic cytochrome P450 2B1 by parathion.
    Murray M; Butler AM
    J Pharmacol Exp Ther; 1995 Feb; 272(2):639-44. PubMed ID: 7853177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.